NYXH
NYXH
NASDAQ · Health Care

Nyxoah Sa

$1.69
+0.04 (+2.42%)
As of Jun 30, 10:27 PM ET ·
Financial Highlights (FY 2026)
Revenue
23.50M
Net Income
-211,305,725
Gross Margin
63.1%
Profit Margin
-899.1%
Rev Growth
+48.1%
D/E Ratio
0.86
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 63.1% 63.1% 48.0% 48.0%
Operating Margin -833.2% -749.9% 7.1% 7.9%
Profit Margin -899.1% -854.1% 6.9% 6.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 23.50M 15.87M 96.72M 100.81M
Gross Profit 14.84M 10.02M 46.41M 48.38M
Operating Income -195,799,499 -118,978,832 6.86M 7.92M
Net Income -211,305,725 -128,401,291 6.66M 6.06M
Gross Margin 63.1% 63.1% 48.0% 48.0%
Operating Margin -833.2% -749.9% 7.1% 7.9%
Profit Margin -899.1% -854.1% 6.9% 6.0%
Rev Growth +48.1% +48.1% -2.0% +4.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 34.02M 34.02M 61.10M 61.83M
Total Equity 39.73M 39.73M 75.28M 67.03M
D/E Ratio 0.86 0.86 0.81 0.92
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -185,302,580 -118,855,884 9.82M 10.80M
Free Cash Flow 3.28M 3.57M